Life Sciences

Sun and Taro reach an agreement on  $348M buyout after ...

Sun Pharmaceutical and Taro Pharmaceutical have formally announced their merger ...

Balversa Receives FDA Approval for Bladder Cancer Treat...

Balversa (erdafitinib) has received complete approval from the FDA, permitting i...

Over 200 layoffs planned by Lonza at clinical productio...

The Swiss Contract Development and Manufacturing Organization (CDMO) is now sign...

Disco Pharmaceuticals Unveils Surfaceome Mapping for En...

Disco Pharmaceuticals has recently taken the pharmaceutical stage, bolstered by ...

BioNTech Allocates $20 Million to WuXi for Two Preclini...

BioNTech, the renowned German biotechnology powerhouse, has engaged in a substan...

Alcon’s Strategic Move: AR-15512 Breakthrough in Dry Ey...

Alcon’s recent acquisition of Aerie Pharmaceuticals for $770 million is proving ...

Approval Granted to Eisai and Biogen’s Leqembi for Alzh...

China has officially granted approval for the sale of Leqembi, a revolutionary A...

Harvard researchers find improved efficacy against reti...

Researchers from Harvard University and the Broad Institute, led by Dr. David Li...

GSK Set to Purchase Aiolos Bio, Expand Respiratory Pipe...

GSK has revealed a contract to acquire Aiolos Bio and its phase 2 asthma medicin...

Novo Nordisk Forges Million-Dollar Research Pacts with ...

In a strategic accord forged in tandem with Flagship Pioneering, Novo Nordisk ha...

Vertex Pharmaceuticals Halts VX-880 Diabetes Drug Trial...

In response to the occurrence of two fatalities within its VX-880 diabetes drug ...

Merck to Acquire Harpoon Therapeutics In a Deal Worth $...

With the agreement to shell out $680 million for Harpoon Therapeutics and its on...

Bayer’s Drug for Menopausal Relief Demonstrates Positiv...

Bayer, the renowned pharmaceutical giant headquartered in Germany, has recently ...

Successful Phase 3 Trials Propel Innovent’s Mazdutide i...

Innovent, a prominent player in the Chinese pharmaceutical landscape, is gearing...

In phase 2 head-to-head comparison, Curevo’s shingles v...

Curevo Vaccine’s bold strategic move to enter the competitive Shingles vaccine m...

Global Approval in the future for AstraZeneca’s Infant ...

AstraZeneca and Sanofi achieved a milestone as their respiratory syncytial virus...